A recent study [76] has evaluated miRNA expression profiles in T1D without other pathologies, and it was observed that the development of a well-established disease, where patients are continuously treated with insulin, may differ from the onset of the disease and, more importantly, from other types of diabetes. The gene discussed is INS; the disease is type 1 diabetes mellitus.